Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-23

Clinical Trial Update: Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pseudoephedrine plus levocetirizine to placebo in vasomotor rhinitis has completed, reporting efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine (Levocetirizine)
  • Pseudoephedrine (Pseudoephedrine)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Vasomotor Rhinitis | Phase 3 | Status: COMPLETED